<HTML>
<HEAD>
<Title>Form S-8</title>
</HEAD>
<BODY>


                       <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>As filed with the Securities and Exchange Commission on April 8, 2002</B></font></P>

                                                                                    <P ALIGN=RIGHT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Registration No. 333-__________</font></P>
<HR SIZE=2 NOSHADE>



                                        <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>SECURITIES AND EXCHANGE COMMISSION<BR>
                                              Washington, D.C. 20549</B></font></P>
 <HR SIZE=1 WIDTH=25% NOSHADE>

                                                     <P ALIGN=CENTER><FONT SIZE=4><B>FORM S-8</b></font><BR>
                                              <FONT FACE="Times New Roman, Times, Serif" SIZE=2><b>REGISTRATION STATEMENT<BR>
                                                       UNDER<BR>
                                            THE SECURITIES ACT OF 1933</B></font></P>
 <HR SIZE=1 WIDTH=25% NOSHADE>

                                          <P ALIGN=CENTER><FONT SIZE=6><B>Martek Biosciences Corporation</B></font><BR>
                              <FONT FACE="Times New Roman, Times, Serif" SIZE=1>(Exact name of registrant as specified in its charter)</font></P>

                                                     <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Delaware</font><BR>
                                          <FONT FACE="Times New Roman, Times, Serif" SIZE=1>(State or other jurisdiction of<BR>
                                          incorporation or organization)</font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52-1399362&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></font><BR>
                                                  <FONT FACE="Times New Roman, Times, Serif" SIZE=1>(I.R.S. Employer Identification No.)</font></P>
<BR>
<BR>

                                                 <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>6480 Dobbin Road<BR>
                                             Columbia, Maryland 21045<BR>
                                                  <U>(410) 740-0081</U></font><BR>
                                <FONT FACE="Times New Roman, Times, Serif" SIZE=1>(Address, including zip code, and telephone number,<BR>
                         including area code, of registrant's principal executive offices)</font></P>
<HR SIZE=1 WIDTH=25% NOSHADE>
                             <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Martek Biosciences Corporation 2002 Stock Incentive Plan</font><BR>
                                             <FONT FACE="Times New Roman, Times, Serif" SIZE=1>(Full title of the Plan)</font></P>
<HR SIZE=1 WIDTH=25% NOSHADE>
                                                   <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Henry Linsert<BR>
                                              Chief Executive Officer<BR>
                                          Martek Biosciences Corporation<BR>
                                                 6480 Dobbin Road<BR>
                                             Columbia, Maryland 21045<BR>
                                                  (410) 740-0081</font></P>

                  <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=1>(Name, address and telephone number, including area code, of agent for service)</font></P>

                                                     <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=1>Copy to:</font><BR>
                                                 <FONT FACE="Times New Roman, Times, Serif" SIZE=2>Michael J. Silver<BR>
                                              Hogan &amp; Hartson L.L.P.<BR>
                                             111 South Calvert Street<BR>
                                             Baltimore, Maryland 21202<BR>
                                                  (410) 659-2700</font></P>

<HR SIZE=1 WIDTH=25% NOSHADE>
                                          <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>CALCULATION OF REGISTRATION FEE</B></font></P>

<hr noshade size="2">
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="75%">
<TR valign="bottom">
        <TD width="59%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="6%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Amount</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed maximum</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed maximum</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Amount of</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1"><B>Title of securities</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>to be</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>offering price</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>aggregate offering</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>registration</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1"><B>to be registered</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>registered</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>per share</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>price</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>fee (1)</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD colspan="3"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD colspan="3"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD colspan="3"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD colspan="3"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
        <TD><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">Common Stock, par value $.10 per share (2)</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">1,682,000</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$30.125</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$50,670,250</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$4,662</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>

</TR>
</TABLE>
</CENTER>
<hr noshade size="2">


<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(1)&nbsp;&nbsp;Estimated pursuant to Rule 457(c) and (h) of the Securities Act of 1933, as amended, solely for the purpose
of calculating the amount of the registration fee, based on the average of the high and low prices per share of
Martek Biosciences Corporation common stock, par value $.10 per share, on April 4, 2002, as reported on the
NASDAQ National Market.</font></P>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(2)&nbsp;&nbsp;Includes  Series A Preferred  Share  Purchase  Rights  attached  thereto,  for which no separate  fee is
      payable pursuant to Rule 457(i).</font></P>

<HR SIZE=2 NOSHADE>



<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>PART I</FONT></H1>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>INFORMATION
REQUIRED IN THE SECTION 10(a) PROSPECTUS</FONT></H1>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The documents  containing the information  specified in Part I will be sent or given to employees
as specified by Rule  428(b)(1) of the  Securities Act of 1933, as amended (the  "Securities  Act").  In accordance
with the  instructions  to Part I of Form S-8, such  documents  will not be filed with the  Securities and Exchange
Commission  (the  "Commission")  either as part of this  registration  statement or as  prospectuses  or prospectus
supplements  pursuant  to Rule 424 of the  Securities  Act.  These  documents  and the  documents  incorporated  by
reference pursuant to Item 3 of Part II of this registration statement,  taken together,  constitute the prospectus
as required by Section 10(a) of the Securities Act.</font></P>


<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>PART II</FONT></H1>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>INFORMATION REQUIRED
IN THE REGISTRATION STATEMENT</FONT></H1>

<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Incorporation of Documents by Reference.</FONT></H2>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Martek  Biosciences  Corporation  (the  "Company")  hereby  incorporates  by reference  into this
registration statement the following documents filed by it with the Commission:</font></P>

<TABLE WIDTH=100%>
<TR>
<TD WIDTH=5%>&nbsp;</TD><TD WIDTH=95%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(a)&nbsp;&nbsp;&nbsp;&nbsp;annual report on form 10-K for the fiscal year ended October 31, 2001;</font></TD>
</TR>
<TR>
<TD WIDTH=5%>&nbsp;</TD><TD WIDTH=95%>&nbsp;</TD>
</TR>
<TR>
<TD WIDTH=5%>&nbsp;</TD><TD WIDTH=95%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(b)&nbsp;&nbsp;&nbsp;&nbsp;quarterly report on form 10-Q for the fiscal quarter ended January 31, 2002;</font></TD>
</TR>
<TR>
<TD WIDTH=5%>&nbsp;</TD><TD WIDTH=95%>&nbsp;</TD>
</TR>
<TR>
<TD WIDTH=5%>&nbsp;</TD><TD WIDTH=95%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(c)&nbsp;&nbsp;&nbsp;&nbsp;current report on form 8-K dated March 26, 2002; and</font></TD>
</TR>
<TR>
<TD WIDTH=5%>&nbsp;</TD><TD WIDTH=95%>&nbsp;</TD>
</TR>
<TR>
<TD WIDTH=5%>&nbsp;</TD><TD WIDTH=95%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(d)&nbsp;&nbsp;&nbsp;&nbsp;the description of Martek&#146;s common stock, $.10 par value per share
contained in the Registrant&#146;s Registration Statement on Form 8-A, including
all amendments and reports filed under Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) for purposes of
updating the description of the common stock.</font></TD>
</TR>
</tABLE>
<BR>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In  addition,  all  documents  and  reports  filed by the Company  subsequent  to the date hereof
pursuant to Sections  13(a),  13(c),  14, and 15(d) of the Exchange  Act,  prior to the filing of a  post-effective
amendment  which  indicates  that all  securities  offered  have  been  sold or which  deregisters  all  securities
remaining  unsold,  shall be deemed to be incorporated by reference in this  registration  statement and to be part
hereof from the date of filing of such  documents or reports.  Any statement  contained in a document  incorporated
or deemed to be  incorporated  by  reference  herein shall be deemed to be modified or  superseded  for purposes of
this  registration  statement  to the extent that a statement  contained  herein or in any other  subsequent  filed
document  which  also  is or is  deemed  to be  incorporated  by  reference  herein  modifies  or  supersedes  such
statement.  Any  such  statement  so  modified  or  superseded  shall  not be  deemed,  except  as so  modified  or
superseded, to constitute a part of this registration statement.</font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>- 2 -</font></P>
<HR SIZE=2 NOSHADE>
<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description of Securities.</FONT></H2>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable (the Common Stock is registered under Section 12(g) of the Exchange Act).</font></P>

<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interests of Named Experts and Counsel.</FONT></H2>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.</font></P>

<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers.</FONT></H2>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under  Section  145 of the  General  Corporation  Law of the State of Delaware  (the  "DGCL"),  a
corporation  may indemnify  its  directors,  officers,  employees  and agents and its former  directors,  officers,
employees  and  agents  and  those who  serve,  at the  corporation's  request,  in such  capacities  with  another
enterprise,  against  expenses  (including  attorney's  fees),  as well as  judgments,  fines  and  settlements  in
nonderivative  lawsuits,  actually and reasonably  incurred in connection  with the defense of any action,  suit or
proceeding  in which they or any of them were or are made  parties or are  threatened  to be made parties by reason
of their serving or having served in such capacity.  The DGCL provides,  however,  that such person must have acted
in good faith and in a manner he or she  reasonably  believed to be in (or not opposed  to) the best  interests  of
the corporation  and, in the case of a criminal  action,  such person must have had no reasonable  cause to believe
his or her conduct was  unlawful.  In addition,  the DGCL does not permit  indemnification  in an action or suit by
or in the right of the  corporation,  where such person has been adjudged liable to the  corporation,  unless,  and
only to the extent that, a court  determines  that such person  fairly and  reasonably is entitled to indemnity for
costs the court deems  proper in light of  liability  adjudication.  Indemnity  is mandatory to the extent a claim,
issue or matter has been successfully defended.</font></P>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Article NINETH of the Company's  Certificate of  Incorporation  provides that the Company will indemnify
its  directors and officers to the full extent  permitted by law and that no director  shall be liable for monetary
damages to the Registrant or its  stockholders  for any breach of fiduciary duty,  except to the extent provided by
applicable law (i) for any breach of the director's  duty of loyalty to the  Registrant or its  stockholders,  (ii)
for acts or omissions not in good faith or which  involve  intentional  misconduct  or a knowing  violation of law,
(iii)  pursuant  to Section  174 of the DGCL,  or (iv) for any  transaction  from which  such  director  derived an
improper personal benefit.  In addition,  under  indemnification  agreements with its directors,  the Registrant is
obligated,  to the fullest extent  permissible by the DGCL, as it currently exists or may be amended,  to indemnify
and hold harmless its directors,  from and against all expense,  liability and loss reasonably incurred or suffered
by such directors.</font></P>

                                                       <P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *</B></font></P>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar as indemnification  for liabilities  arising under the Securities Act may be permitted to
directors,  officers,  and controlling persons of the Company pursuant to the foregoing  provisions,  or otherwise,
the  Registrant  has been advised that in the opinion of the  Commission  such  indemnification  is against  public
policy  as  expressed  in the  Securities  Act and is,  therefore,  unenforceable.  In the  event  that a claim for
indemnification  against such  liabilities  (other than the payment by the Registrant of expenses  incurred or paid
by a director,  officer or controlling  person of the Registrant in the successful  defense of any action,  suit or
proceeding) is asserted by such director,  officer or controlling  person in connection  with the securities  being
registered,  the Company  will,  unless in the opinion of its  counsel the matter has been  settled by  controlling
precedent,  submit to a court of  appropriate  jurisdiction  the  question  whether such  indemnification  by it is
against  public policy as expressed in the Securities  Act and will be governed by the final  adjudication  of such
issue.</font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>- 3 -</font></P>
<HR SIZE=2 NOSHADE>
<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exemption from Registration Claimed.</FONT></H2>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.</font></P>

<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.</FONT></H2>


<table>
<TR>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Exhibit<BR><U>Number</U></font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;<BR><u>Description</U></font></td>
</tr>
<TR>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>4.01</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Specimen Stock Certificate for Common Stock (Incorporated by reference as an Exhibit to the Registrant's Registration on Form S-1 (No. 333-68522))</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>4.02</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Form of Rights Agreement dated as of January 24, 1996 between the Registrant and Registrar and Transfer Company, as Rights Agent (Incorporated by reference as Exhibit 1 to the Registrant&#146;s Form 8-K, File No. 0-22354, filed January 29, 1996)
</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>4.03</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Form of First Amendment to Rights Agreement between the Registrant and Registrar and Transfer Company, as Rights Agent (Incorporated by reference as Exhibit 99.1 to the Registrant's Form 8-K, File No. 0-22354, filed November 9, 1998)
</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>5.01</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Opinion regarding the legality of the shares of Common Stock being registered</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>10.01</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>2002 Stock Incentive Plan (filed as Exhibit I to the Registrant's 2002 Proxy Statement and incorporated by reference herein.  File No. 0-22354)
</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>23.01</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Consent of Ernst &amp; Young LLP</font></td>
</tr>
<TR>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>23.02</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Consent of Hogan &amp; Hartson L.L.P. (contained in Exhibit 5.01)</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<td><FONT FACE="Times New Roman, Times, Serif" SIZE=2>24</font></td><td width=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Power of Attorney (contained on signature page)</font></td>
</tr>
</table>

<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Undertakings.</font></H2>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Registrant hereby undertakes:</font></p>

<table>
<TR VALIGN=TOP>
<TD WIDTH=10%>&nbsp;</TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(1)&nbsp;&nbsp;&nbsp;&nbsp;To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:</font></TD></tr>
</table>
<BR>
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=15%>&nbsp;</TD>
<TD WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To include any prospectus required by Section 10(a)(3) of the Securities Act;</font></TD>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=15%>&nbsp;</TD>
<TD WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=15%>&nbsp;</TD>
<TD WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To reflect in the prospectus any facts or events arising after the effective
date of the registration statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20% change in the maximum aggregate offering
price set forth in the &#147;Calculation of Registration Fee&#148; table in the
effective registration statement;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=15%>&nbsp;</TD>
<TD WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
</tr>
</table>
<BR>
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>- 4 -</font></P>
<HR SIZE=2 NOSHADE>
<table>
<TR VALIGN=TOP>
<TD WIDTH=15%>&nbsp;</TD>
<TD WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To include any material information with respect to the plan of distribution not
previously disclosed in the registration statement or any material change to
such information in the registration statement.</FONT></TD>
</TR>
</TABLE>
<BR>
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=10%>&nbsp;</TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provided,  however,  that  paragraphs  (a)(1)(i)  and  (a)(1)(ii)  do not  apply  if the
                  registration  statement is on Form S-3, or Form S-8, and the information  required to be included
                  in a  post-effective  amendment by those paragraphs is contained in periodic reports filed by the
                  Registrant  pursuant to Section 13 or Section 15(d) of the Exchange Act that are  incorporated by
                  reference in the registration statement.</font></TD>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=10%>&nbsp;</TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD></tr>
<TR VALIGN=TOP>
<TD WIDTH=10%>&nbsp;</TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(2)&nbsp;&nbsp;&nbsp;&nbsp;That, for the purpose of determining  any liability  under the Securities  Act,
                  each such  post-effective  amendment shall be deemed to be a new registration  statement relating
                  to the  securities  offered  therein,  and the offering of such  securities at that time shall be
                  deemed to be the initial bona fide offering thereof.</font></TD>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=10%>&nbsp;</TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=10%>&nbsp;</TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(3)&nbsp;&nbsp;&nbsp;&nbsp;To remove from  registration by means of a post-effective  amendment any of the
                  securities being registered which remain unsold at the termination of the offering.</font></TD>
</tr>
</table>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;The  undersigned  Registrant  hereby  undertakes  that, for purposes of determining any liability
under the  Securities  Act,  each filing of the  Registrant's  annual  report  pursuant to Section 13(a) or Section
15(d) of the  Exchange  Act (and,  where  applicable,  each  filing of an employee  benefit  plan's  annual  report
pursuant to Section  15(d) of the Exchange Act) that is  incorporated  by reference in the  registration  statement
shall be deemed to be a new registration  statement  relating to the securities  offered therein,  and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></p>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;The undertaking concerning indemnification is set forth under the response to Item 6.</font></p>



<p align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>- 5 -</font></p>
<HR SIZE=2 NOSHADE>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>SIGNATURES</FONT></H1>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Pursuant to the
requirements of the Securities Act, the Registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing
on Form S-8 and has duly caused this Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the County of Howard,
Maryland, on April 8, 2002. </FONT></P>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=50%>&nbsp;</TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Martek Biosciences Corporation<BR>
                                                                <BR>
                                                                By:&nbsp;&nbsp;&nbsp;&nbsp;<U>/s/ Henry Linsert, Jr.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Henry Linsert, Jr.<BR>
                                                                &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</font></td>
</tr>
</table>
<BR>
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Pursuant to the
requirements of the Securities Act of 1933, this Registration Statement has been
signed by the following persons in the capacities and on the date indicated. </FONT></P>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>We, the undersigned
officers and directors of Martek Biosciences Corporation, hereby severally and
individually constitute and appoint Henry Linsert, Jr., Peter L. Buzy and
Michael J. Silver, and each of them, the true and lawful attorneys and agents of
each of us to execute in the name, place and stead of each of us (individually
and in any capacity stated below) any and all amendments to this Registration
Statement on Form S-8, and all instruments necessary or advisable in connection
therewith and to file the same with the Securities and Exchange Commission, each
of said attorneys and agents to have power to act with or without the other and
to have full power and authority to do and perform in the name and on behalf of
each of the undersigned every act whatsoever necessary or advisable to be done
in the premises as fully and to all intents and purposes as any of the
undersigned might or could do in person, and we hereby ratify and confirm our
signatures as they may be signed by our said attorneys and agents and each of
them to any and all such amendment and amendments. </FONT></P>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  Henry Linsert, Jr.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                                Henry Linsert, Jr.<BR>
                                                                Chief Executive Officer and Director<BR>
                                                                (Principal Executive Officer)</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  Peter L. Buzy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                                Peter L. Buzy<BR>
                                                                (Chief Financial and Accounting Officer)</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  Jules Blake&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                                Jules Blake<BR>
                                                                Director</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U> /s/  Gordon S. Macklin&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                                Gordon S. Macklin<BR>
                                                                Director</font></td>
</tr>
</table>
<BR>
<p align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>- 6 -</font></p>
<HR SIZE=2 NOSHADE>
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  Ann L. Johnson&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                                Ann L. Johnson<BR>
                                                                Director</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  John H. Mahar&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                     John H. Mahar<BR>
                                                     Director</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  Sandra Panem&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                     Sandra Panem<BR>
                                                     Director</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  Richard J. Radmer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                     Richard J. Radmer<BR>
                                                     Director</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  Eugene H. Rotberg&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                     Eugene H. Rotberg<BR>
                                                     Director</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</font></td>
</tr>
<TR VALIGN=TOP>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date: April 8, 2002</font></TD>
<TD WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>/s/  William D. Smart&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
                                                     William D. Smart<BR>
                                                     Director</font></td>
</tr>
</table>
<BR>
<p align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>- 7 -</font></p>
<HR SIZE=2 NOSHADE>
</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "fs8_040802-matk.htm", "description": "FORM S-8", "secsgml_size_bytes": 41998}]
{"company-data": {"conformed-name": "MARTEK BIOSCIENCES CORP", "cik": "0000892025", "assigned-sic": "2836", "irs-number": "521399362", "state-of-incorporation": "DE", "fiscal-year-end": "1031"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-85856", "film-number": "02604881"}, "business-address": {"street1": "6480 DOBBIN RD", "city": "COLUMBIA", "state": "MD", "zip": "21045", "phone": "4107400081"}, "mail-address": {"street1": "6480 DOBBIN RD", "city": "COLUMBIA", "state": "MD", "zip": "21045"}}
Form S-8
As filed with the Securities and Exchange Commission on April 8, 2002
Registration No. 333-__________
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Martek Biosciences Corporation
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
52-1399362
(I.R.S. Employer Identification No.)
6480 Dobbin Road
Columbia, Maryland 21045
(410) 740-0081
(Address, including zip code, and telephone number,
including area code, of registrant's principal executive offices)
Martek Biosciences Corporation 2002 Stock Incentive Plan
(Full title of the Plan)
Henry Linsert
Chief Executive Officer
Martek Biosciences Corporation
6480 Dobbin Road
Columbia, Maryland 21045
(410) 740-0081
(Name, address and telephone number, including area code, of agent for service)
Copy to:
Michael J. Silver
Hogan & Hartson L.L.P.
111 South Calvert Street
Baltimore, Maryland 21202
(410) 659-2700
CALCULATION OF REGISTRATION FEE
Amount
Proposed maximum
Proposed maximum
Amount of
Title of securities
to be
offering price
aggregate offering
registration
to be registered
registered
per share
price
fee (1)
Common Stock, par value $.10 per share (2)
1,682,000
$30.125
$50,670,250
$4,662
(1)  Estimated pursuant to Rule 457(c) and (h) of the Securities Act of 1933, as amended, solely for the purpose
of calculating the amount of the registration fee, based on the average of the high and low prices per share of
Martek Biosciences Corporation common stock, par value $.10 per share, on April 4, 2002, as reported on the
NASDAQ National Market.
(2)  Includes  Series A Preferred  Share  Purchase  Rights  attached  thereto,  for which no separate  fee is
      payable pursuant to Rule 457(i).
PART I
INFORMATION
REQUIRED IN THE SECTION 10(a) PROSPECTUS
The documents  containing the information  specified in Part I will be sent or given to employees
as specified by Rule  428(b)(1) of the  Securities Act of 1933, as amended (the  "Securities  Act").  In accordance
with the  instructions  to Part I of Form S-8, such  documents  will not be filed with the  Securities and Exchange
Commission  (the  "Commission")  either as part of this  registration  statement or as  prospectuses  or prospectus
supplements  pursuant  to Rule 424 of the  Securities  Act.  These  documents  and the  documents  incorporated  by
reference pursuant to Item 3 of Part II of this registration statement,  taken together,  constitute the prospectus
as required by Section 10(a) of the Securities Act.
PART II
INFORMATION REQUIRED
IN THE REGISTRATION STATEMENT
Item 3.     
Incorporation of Documents by Reference.
Martek  Biosciences  Corporation  (the  "Company")  hereby  incorporates  by reference  into this
registration statement the following documents filed by it with the Commission:
(a)    annual report on form 10-K for the fiscal year ended October 31, 2001;
(b)    quarterly report on form 10-Q for the fiscal quarter ended January 31, 2002;
(c)    current report on form 8-K dated March 26, 2002; and
(d)    the description of Martek's common stock, $.10 par value per share
contained in the Registrant's Registration Statement on Form 8-A, including
all amendments and reports filed under Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") for purposes of
updating the description of the common stock.
In  addition,  all  documents  and  reports  filed by the Company  subsequent  to the date hereof
pursuant to Sections  13(a),  13(c),  14, and 15(d) of the Exchange  Act,  prior to the filing of a  post-effective
amendment  which  indicates  that all  securities  offered  have  been  sold or which  deregisters  all  securities
remaining  unsold,  shall be deemed to be incorporated by reference in this  registration  statement and to be part
hereof from the date of filing of such  documents or reports.  Any statement  contained in a document  incorporated
or deemed to be  incorporated  by  reference  herein shall be deemed to be modified or  superseded  for purposes of
this  registration  statement  to the extent that a statement  contained  herein or in any other  subsequent  filed
document  which  also  is or is  deemed  to be  incorporated  by  reference  herein  modifies  or  supersedes  such
statement.  Any  such  statement  so  modified  or  superseded  shall  not be  deemed,  except  as so  modified  or
superseded, to constitute a part of this registration statement.
- 2 -
Item 4.     Description of Securities.
Not applicable (the Common Stock is registered under Section 12(g) of the Exchange Act).
Item 5.     Interests of Named Experts and Counsel.
Not applicable.
Item 6.     Indemnification of Directors and Officers.
Under  Section  145 of the  General  Corporation  Law of the State of Delaware  (the  "DGCL"),  a
corporation  may indemnify  its  directors,  officers,  employees  and agents and its former  directors,  officers,
employees  and  agents  and  those who  serve,  at the  corporation's  request,  in such  capacities  with  another
enterprise,  against  expenses  (including  attorney's  fees),  as well as  judgments,  fines  and  settlements  in
nonderivative  lawsuits,  actually and reasonably  incurred in connection  with the defense of any action,  suit or
proceeding  in which they or any of them were or are made  parties or are  threatened  to be made parties by reason
of their serving or having served in such capacity.  The DGCL provides,  however,  that such person must have acted
in good faith and in a manner he or she  reasonably  believed to be in (or not opposed  to) the best  interests  of
the corporation  and, in the case of a criminal  action,  such person must have had no reasonable  cause to believe
his or her conduct was  unlawful.  In addition,  the DGCL does not permit  indemnification  in an action or suit by
or in the right of the  corporation,  where such person has been adjudged liable to the  corporation,  unless,  and
only to the extent that, a court  determines  that such person  fairly and  reasonably is entitled to indemnity for
costs the court deems  proper in light of  liability  adjudication.  Indemnity  is mandatory to the extent a claim,
issue or matter has been successfully defended.
Article NINETH of the Company's  Certificate of  Incorporation  provides that the Company will indemnify
its  directors and officers to the full extent  permitted by law and that no director  shall be liable for monetary
damages to the Registrant or its  stockholders  for any breach of fiduciary duty,  except to the extent provided by
applicable law (i) for any breach of the director's  duty of loyalty to the  Registrant or its  stockholders,  (ii)
for acts or omissions not in good faith or which  involve  intentional  misconduct  or a knowing  violation of law,
(iii)  pursuant  to Section  174 of the DGCL,  or (iv) for any  transaction  from which  such  director  derived an
improper personal benefit.  In addition,  under  indemnification  agreements with its directors,  the Registrant is
obligated,  to the fullest extent  permissible by the DGCL, as it currently exists or may be amended,  to indemnify
and hold harmless its directors,  from and against all expense,  liability and loss reasonably incurred or suffered
by such directors.
*      *      *
Insofar as indemnification  for liabilities  arising under the Securities Act may be permitted to
directors,  officers,  and controlling persons of the Company pursuant to the foregoing  provisions,  or otherwise,
the  Registrant  has been advised that in the opinion of the  Commission  such  indemnification  is against  public
policy  as  expressed  in the  Securities  Act and is,  therefore,  unenforceable.  In the  event  that a claim for
indemnification  against such  liabilities  (other than the payment by the Registrant of expenses  incurred or paid
by a director,  officer or controlling  person of the Registrant in the successful  defense of any action,  suit or
proceeding) is asserted by such director,  officer or controlling  person in connection  with the securities  being
registered,  the Company  will,  unless in the opinion of its  counsel the matter has been  settled by  controlling
precedent,  submit to a court of  appropriate  jurisdiction  the  question  whether such  indemnification  by it is
against  public policy as expressed in the Securities  Act and will be governed by the final  adjudication  of such
issue.
- 3 -
Item 7.     Exemption from Registration Claimed.
Not applicable.
Item 8.     Exhibits.
Exhibit
Number
Description
4.01
Specimen Stock Certificate for Common Stock (Incorporated by reference as an Exhibit to the Registrant's Registration on Form S-1 (No. 333-68522))
4.02
Form of Rights Agreement dated as of January 24, 1996 between the Registrant and Registrar and Transfer Company, as Rights Agent (Incorporated by reference as Exhibit 1 to the Registrant's Form 8-K, File No. 0-22354, filed January 29, 1996)
4.03
Form of First Amendment to Rights Agreement between the Registrant and Registrar and Transfer Company, as Rights Agent (Incorporated by reference as Exhibit 99.1 to the Registrant's Form 8-K, File No. 0-22354, filed November 9, 1998)
5.01
Opinion regarding the legality of the shares of Common Stock being registered
10.01
2002 Stock Incentive Plan (filed as Exhibit I to the Registrant's 2002 Proxy Statement and incorporated by reference herein.  File No. 0-22354)
23.01
Consent of Ernst & Young LLP
23.02
Consent of Hogan & Hartson L.L.P. (contained in Exhibit 5.01)
24
Power of Attorney (contained on signature page)
Item 9.     Undertakings.
(a)    The undersigned Registrant hereby undertakes:
(1)    To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(i)     To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)     To reflect in the prospectus any facts or events arising after the effective
date of the registration statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20% change in the maximum aggregate offering
price set forth in the "Calculation of Registration Fee" table in the
effective registration statement;
- 4 -
(iii)     To include any material information with respect to the plan of distribution not
previously disclosed in the registration statement or any material change to
such information in the registration statement.
Provided,  however,  that  paragraphs  (a)(1)(i)  and  (a)(1)(ii)  do not  apply  if the
                  registration  statement is on Form S-3, or Form S-8, and the information  required to be included
                  in a  post-effective  amendment by those paragraphs is contained in periodic reports filed by the
                  Registrant  pursuant to Section 13 or Section 15(d) of the Exchange Act that are  incorporated by
                  reference in the registration statement.
(2)    That, for the purpose of determining  any liability  under the Securities  Act,
                  each such  post-effective  amendment shall be deemed to be a new registration  statement relating
                  to the  securities  offered  therein,  and the offering of such  securities at that time shall be
                  deemed to be the initial bona fide offering thereof.
(3)    To remove from  registration by means of a post-effective  amendment any of the
                  securities being registered which remain unsold at the termination of the offering.
(b)    The  undersigned  Registrant  hereby  undertakes  that, for purposes of determining any liability
under the  Securities  Act,  each filing of the  Registrant's  annual  report  pursuant to Section 13(a) or Section
15(d) of the  Exchange  Act (and,  where  applicable,  each  filing of an employee  benefit  plan's  annual  report
pursuant to Section  15(d) of the Exchange Act) that is  incorporated  by reference in the  registration  statement
shall be deemed to be a new registration  statement  relating to the securities  offered therein,  and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c)    The undertaking concerning indemnification is set forth under the response to Item 6.
- 5 -
SIGNATURES
Pursuant to the
requirements of the Securities Act, the Registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing
on Form S-8 and has duly caused this Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the County of Howard,
Maryland, on April 8, 2002.
Martek Biosciences Corporation
By:
/s/ Henry Linsert, Jr.
Henry Linsert, Jr.
Chief Executive Officer
Pursuant to the
requirements of the Securities Act of 1933, this Registration Statement has been
signed by the following persons in the capacities and on the date indicated.
We, the undersigned
officers and directors of Martek Biosciences Corporation, hereby severally and
individually constitute and appoint Henry Linsert, Jr., Peter L. Buzy and
Michael J. Silver, and each of them, the true and lawful attorneys and agents of
each of us to execute in the name, place and stead of each of us (individually
and in any capacity stated below) any and all amendments to this Registration
Statement on Form S-8, and all instruments necessary or advisable in connection
therewith and to file the same with the Securities and Exchange Commission, each
of said attorneys and agents to have power to act with or without the other and
to have full power and authority to do and perform in the name and on behalf of
each of the undersigned every act whatsoever necessary or advisable to be done
in the premises as fully and to all intents and purposes as any of the
undersigned might or could do in person, and we hereby ratify and confirm our
signatures as they may be signed by our said attorneys and agents and each of
them to any and all such amendment and amendments.
Date: April 8, 2002
/s/  Henry Linsert, Jr.
Henry Linsert, Jr.
Chief Executive Officer and Director
(Principal Executive Officer)
Date: April 8, 2002
/s/  Peter L. Buzy
Peter L. Buzy
(Chief Financial and Accounting Officer)
Date: April 8, 2002
/s/  Jules Blake
Jules Blake
Director
Date: April 8, 2002
/s/  Gordon S. Macklin
Gordon S. Macklin
Director
- 6 -
Date: April 8, 2002
/s/  Ann L. Johnson
Ann L. Johnson
Director
Date: April 8, 2002
/s/  John H. Mahar
John H. Mahar
Director
Date: April 8, 2002
/s/  Sandra Panem
Sandra Panem
Director
Date: April 8, 2002
/s/  Richard J. Radmer
Richard J. Radmer
Director
Date: April 8, 2002
/s/  Eugene H. Rotberg
Eugene H. Rotberg
Director
Date: April 8, 2002
/s/  William D. Smart
William D. Smart
Director
- 7 -